Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.51)
# 3,406
Out of 5,072 analysts
175
Total ratings
45.95%
Success rate
-1.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $105.35 | +11.06% | 11 | Nov 19, 2025 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $4 → $6 | $8.10 | -25.93% | 17 | Nov 10, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $188.30 | -21.93% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $97.07 | -2.13% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $578.87 | +12.29% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $13.58 | -11.63% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $146.00 | -34.93% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $79.66 | +6.70% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $46.83 | -67.97% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $328.82 | +4.31% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.70 | +723.53% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $18.66 | +157.23% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $86.82 | +17.48% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $101.36 | -42.78% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.89 | +25.87% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $61.69 | +112.35% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $128.05 | +3.87% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $375.08 | -41.35% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $114.70 | +229.56% | 2 | Feb 25, 2022 |
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $105.35
Upside: +11.06%
Sight Sciences
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $4 → $6
Current: $8.10
Upside: -25.93%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $188.30
Upside: -21.93%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $97.07
Upside: -2.13%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $578.87
Upside: +12.29%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $13.58
Upside: -11.63%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $146.00
Upside: -34.93%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $79.66
Upside: +6.70%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $46.83
Upside: -67.97%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $328.82
Upside: +4.31%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.70
Upside: +723.53%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $18.66
Upside: +157.23%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $86.82
Upside: +17.48%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $101.36
Upside: -42.78%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.89
Upside: +25.87%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $61.69
Upside: +112.35%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $128.05
Upside: +3.87%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $375.08
Upside: -41.35%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $114.70
Upside: +229.56%